Rasburicase and hyperbilirubinaemia Patient Reports February 12, 2012

Rasburicase Side Effects Report #4572201-3
Rasburicase side effect was reported by a Consumer or non-health professional from on Jan 03, 2005. Male patient, 55 years of age, weighting 171.3 lb, was diagnosed with hyperuricaemia, leukaemia, neoplasm malignant and was treated with Rasburicase. After drug was administered, patient experienced the following side effects: haemolysis, hyperbilirubinaemia. Rasburicase dosage: 0.2 MG/KG QD - INTRAVENOUSNOS. During the same period patient was treated with CYTARABINE, IDARUBICIN, VALSARTAN, GRANISETRON, DEXAMETHASONE. Patient recovered.

Rasburicase Side Effects Report #4579890-8
Rasburicase side effect was reported by a Consumer or non-health professional from on Jan 20, 2005. Male patient, 55 years of age, weighting 171.3 lb, was diagnosed with hyperuricaemia and was treated with Rasburicase. After drug was administered, patient experienced the following side effects: anaemia, haemolysis, hyperbilirubinaemia, platelet count decreased. Rasburicase dosage: H0.2 MG/KG QD -INTRAVENOUS NOS. During the same period patient was treated with CYTARABINE, IDARUBICIN, VALSARTAN, GRANISETRON, DEXAMETHASONE. Patient recovered.